OA21.04 Amivantamab in Patients with Advanced NSCLC and MET Exon 14 Skipping Mutation: Results from the CHRYSALIS Study

N. Leighl, Byoung Chul Cho, Sandrine Hiret, Ji‐Youn Han, Ki Hyeong Lee, Casilda Llácer Pérez, Matthew Krebs, Filippo de Braud, Eric B. Haura, Rachel E. Sanborn, J.C-H. Yang, Catherine A. Shu, Keiko Goto, Makoto Nishio, J. Zhao, Z. Wang, P. Tomasini, Enriqueta Felip, Jonathan W. Goldman, S.‐H.I. Ou, Michael Boyer, Grace Gao, Su Qu, Joshua C. Curtin, X. Lyu, Amy Roshak, R.W. Schnepp, Philip Kim, Jennifer A. Mertz, Meena Thayu, S. Martin Shreeve, Roland E. Knoblauch, Alexander I. Spira